Surveillance of Bacterial Resistance in a Hospital in Quanzhou from 2023 to 2025
Chen Xiaoting1, Zhou Jingqi2, Hu Liping1, Zhu Yan1, *
1. Central Laboratory,Quanzhou First Affiliated Hospital of Fujian Medical University,Quanzhou 362000,Fujian,China; 2. Central Laboratory,Quanzhou infectious disease hospital of Fujian Province,Quanzhou 362100,Fujian,China
Abstract：Objective To understand the sensitivity and resistance of clinical isolates to common antibiotics in Quanzhou Municipal First Hospital from 2023 to 2025. Methods From January 2023 to December 2025,non-repetitive pathogenic bacteria isolated from various clinical departments of Quanzhou First Hospital were collected.These bacteria were identified and subjected to drug susceptibility analysis using automated instrument methods,mass spectrometry,microbroth dilution,disk diffusion,and E-test methods. Results A total of 18707 nonduplicate isolates were collected for 3 years,including gram-negative bacteria(12478,66.7%)and gram-positive microorganisms(6229,33.3%).The detection rates of S.aureus(MRSA)were 22.4%,teicoplanin(TEC)、Vancomycin(VA)and linezolid(LZD)resistant staphylococci were not isolated.A few vancomycin and LZD resistant strains were identified in Enterococcus.Most of the Enterobacter in our hospital are still highly sensitive to carbapenems.The resistance rate of Acinetobacter baumannii to antibiotics other than polymyxin B(PMB)and tigecycline(TGC)is close to or higher than 30%.Carbapenem-resistant H.influenzae strains were not isolated. Conclusion Surveillance of bacterial resistance for 3 years in our hospital suggests that carbapenem-resistant Enterobacterales and baumanii are still on the rise.It is necessary to stewardship of antimicrobial agents and strengthen hospital infection control.
陈晓婷, 周静琪, 胡丽萍, 朱焱. 2023~2025年泉州市某院细菌耐药性监测[J]. 哈尔滨医药, 2026, 46(5): 49-53.
Chen Xiaoting, Zhou Jingqi, Hu Liping, Zhu Yan. Surveillance of Bacterial Resistance in a Hospital in Quanzhou from 2023 to 2025. journal1, 2026, 46(5): 49-53.
2026, Vol. 46 
